Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis

Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis

Background: We conducted a systematic review and meta-analysis of the cardiovascular, kidney, and safety outcomes of sodium-glucose cotransporter 2 inhibitors (SGLT2i) among patients with diabetic kidney disease (DKD). Methods: We searched electronic databases for major randomized placebo-controlled...

Full description

Bibliographic Details
Main Authors: Kaze, A.D (Author), Kim, S.C (Author), Paik, J.M (Author), Patorno, E. (Author), Zhuo, M. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
acute kidney failure
all cause mortality
Article
Cardiovascular outcomes
Caucasian
cerebrovascular accident
confidence interval
diabetic ketoacidosis
Diabetic kidney disease
diabetic nephropathy
drug safety
end stage renal disease
estimated glomerular filtration rate
follow up
fracture
hazard ratio
heart death
heart failure
heart infarction
hospitalization
human
hyperkalemia
hypovolemia
Kidney outcomes
medical research
meta analysis
Meta-analysis
mortality
mycosis
non insulin dependent diabetes mellitus
placebo
risk reduction
Safety
SGLT2 inhibitors
sodium glucose cotransporter 2 inhibitor
systematic review
treatment outcome
urinary tract infection
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items